PRAF3 induces apoptosis and inhibits migration and invasion in human esophageal squamous cell carcinoma

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Shi, Guo Zhen ^b   Yuan, Yang ^a   Jiang, Guo Jun ^b   Ge, Zhi Jun ^b   Zhou, Jian ^b   Gong, De Jun ^a   Tao, Jing ^a   Tan, Yong Fei ^b   Huang, Sheng Dong ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b YIXING PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANTIMETASTATIC AGENT; CASPASE 8; CASPASE 9; GELATINASE A; GELATINASE B; LIPOCORTIN 5; MESSENGER RNA; PRENYLATED RAB ACCEPTOR 1 DOMAIN FAMILY MEMBER 3 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; ARL6IP5 PROTEIN, HUMAN; HEAT SHOCK PROTEIN; SIGNAL PEPTIDE;

ADULT; APOPTOSIS; ARTICLE; ATADENOVIRUS; CANCER GRADING; CANCER INVASION; CANCER STAGING; CANCER TISSUE; CARCINOMA CELL; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS INHIBITION; MOUSE; NONHUMAN; CELL MOTION; DRUG EFFECT; ESOPHAGUS TUMOR; GENETICS; IMMUNOHISTOCHEMISTRY; LYMPH NODE; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CASPASE 8; CASPASE 9; CELL LINE, TUMOR; CELL MOVEMENT; ESOPHAGEAL NEOPLASMS; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPH NODES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84862786635     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-97     Document Type: Article

References (30)

1. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003, 349(23):2241-2252. 10.1056/NEJMra035010, 14657432.
2. Law S, Wong J. Current management of esophageal cancer. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract 2005, 9(2):291-310.
3. Gamliel Z, Krasna MJ. Multimodality treatment of esophageal cancer. Surg Clin North Am 2005, 85(3):621-630. 10.1016/j.suc.2005.01.011, 15927656.
4. Wang X, Tian X, Liu F, Zhao Y, Sun M, Chen D, Lu C, Wang Z, Shi X, Zhang Q, Zhang D, Shen Z, Li F, Harris CC, Cai H, Ke Y. Detection of HPV DNA in esophageal cancer specimens from different regions and ethnic groups: a descriptive study. BMC Cancer 2010, 10:19. 10.1186/1471-2407-10-19, 2826296, 20078887.
5. Ikemoto MJ, Inoue K, Akiduki S, Osugi T, Imamura T, Ishida N, Ohtomi M. Identification of addicsin/GTRAP3-18 as a chronic morphine-augmented gene in amygdala. Neuroreport 2002, 13(16):2079-2084. 10.1097/00001756-200211150-00018, 12438930.
6. Maier S, Reiterer V, Ruggiero AM, Rothstein JD, Thomas S, Dahm R, Sitte HH, Farhan H. GTRAP3-18 serves as a negative regulator of Rab1 in protein transport and neuronal differentiation. J Cell Mol Med 2009, 13(1):114-124.
7. Chen H, Bai J, Ye J, Liu Z, Chen R, Mao W, Li A, Zhou J. JWA as a functional molecule to regulate cancer cells migration via MAPK cascades and F-actin cytoskeleton. Cell Signal 2007, 19(6):1315-1327. 10.1016/j.cellsig.2007.01.007, 17336041.
8. Wang GL, Shi X, Salisbury E, Timchenko NA. Regulation of apoptotic and growth inhibitory activities of C/EBPalpha in different cell lines. Exp Cell Res 2008, 314(7):1626-1639. 10.1016/j.yexcr.2008.01.028, 3228643, 18313667.
9. Zhou J, Ye J, Zhao X, Li A. JWA is required for arsenic trioxide induced apoptosis in HeLa and MCF-7 cells via reactive oxygen species and mitochondria linked signal pathway. Toxicology and applied pharmacology 2008, 230(1):33-40. 10.1016/j.taap.2008.01.041, 18387645.
10. Bai J, Zhang J, Wu J, Shen L, Zeng J, Ding J, Wu Y, Gong Z, Li A, Xu S, Zhou J, Li G. JWA regulates melanoma metastasis by integrin alphaVbeta3 signaling. Oncogene 2010, 29(8):1227-1237. 10.1038/onc.2009.408, 19946336.
11. Vento MT, Zazzu V, Loffreda A, Cross JR, Downward J, Stoppelli MP, Iaccarino I. Praf2 is a novel Bcl-xL/Bcl-2 interacting protein with the ability to modulate survival of cancer cells. PLoS ONE 2010, 5(12):e15636. 10.1371/journal.pone.0015636, 3006391, 21203533.
12. Guo F, Liu Y, Li Y, Li G. Inhibition of ADP-ribosylation factor-like 6 interacting protein 1 suppresses proliferation and reduces tumor cell invasion in CaSki human cervical cancer cells. Molecular biology reports 2010, 37(8):3819-3825. 10.1007/s11033-010-0037-y, 20213509.
13. Borsics T, Lundberg E, Geerts D, Koomoa DL, Koster J, Wester K, Bachmann AS. Subcellular distribution and expression of prenylated Rab acceptor 1 domain family, member 2 (PRAF2) in malignant glioma: Influence on cell survival and migration. Cancer Sci 2010, 101(7):1624-1631. 10.1111/j.1349-7006.2010.01570.x, 20412121.
14. Hou G, Xue L, Lu Z, Fan T, Tian F, Xue Y. An activated mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by rapamycin and siRNA against mTOR. Cancer Lett 2007, 253(2):236-248. 10.1016/j.canlet.2007.01.026, 17360108.
15. Gratas C, Tohma Y, Barnas C, Taniere P, Hainaut P, Ohgaki H. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer. Cancer Res 1998, 58(10):2057-2062.
16. Elmore S. Apoptosis: a review of programmed cell death. Toxicologic pathology 2007, 35(4):495-516. 10.1080/01926230701320337, 2117903, 17562483.
17. Gupta S. Molecular signaling in death receptor and mitochondrial pathways of apoptosis (Review). Int J Oncol 2003, 22(1):15-20.
18. Samantaray S, Sharma R, Chattopadhyaya TK, Gupta SD, Ralhan R. Increased expression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma. Journal of cancer research and clinical oncology 2004, 130(1):37-44. 10.1007/s00432-003-0500-4, 14569466.
19. Guo W, Giancotti FG. Integrin signalling during tumour progression. Nature reviews Molecular cell biology 2004, 5(10):816-826. 10.1038/nrm1490, 15459662.
20. Chuang JY, Yang WH, Chen HT, Huang CY, Tan TW, Lin YT, Hsu CJ, Fong YC, Tang CH. CCL5/CCR5 axis promotes the motility of human oral cancer cells. J Cell Physiol 2009, 220(2):418-426. 10.1002/jcp.21783, 19334035.
21. Schweneker M, Bachmann AS, Moelling K. JM4 is a four-transmembrane protein binding to the CCR5 receptor. FEBS Lett 2005, 579(7):1751-1758. 10.1016/j.febslet.2005.02.037, 15757671.
22. Bucci C, Chiariello M, Lattero D, Maiorano M, Bruni CB. Interaction cloning and characterization of the cDNA encoding the human prenylated rab acceptor (PRA1). Biochem Biophys Res Commun 1999, 258(3):657-662. 10.1006/bbrc.1999.0651, 10329441.
23. Compton SL, Kemppainen RJ, Behrend EN. Prenylated Rab acceptor domain family member 1 is involved in stimulated ACTH secretion and inhibition. Cell Signal 2009, 21(12):1901-1909. 10.1016/j.cellsig.2009.08.007, 19733236.
24. Mao WG, Liu ZL, Chen R, Li AP, Zhou JW. JWA is required for the antiproliferative and pro-apoptotic effects of all-trans retinoic acid in Hela cells. Clinical and experimental pharmacology & physiology 2006, 33(9):816-824. 10.1111/j.1440-1681.2006.04446.x, 22488110.
25. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001, 411(6835):342-348. 10.1038/35077213, 11357141.
26. Allan LA, Clarke PR. Apoptosis and autophagy: Regulation of caspase-9 by phosphorylation. The FEBS journal 2009, 276(21):6063-6073. 10.1111/j.1742-4658.2009.07330.x, 19788417.
27. Kruidering M, Evan GI. Caspase-8 in apoptosis: the beginning of "the end"?. IUBMB life 2000, 50(2):85-90.
28. Littlepage LE, Sternlicht MD, Rougier N, Phillips J, Gallo E, Yu Y, Williams K, Brenot A, Gordon JI, Werb Z. Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression. Cancer Res 2010, 70(6):2224-2234. 10.1158/0008-5472.CAN-09-3515, 2840052, 20215503.
29. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010, 141(1):52-67. 10.1016/j.cell.2010.03.015, 2862057, 20371345.
30. Deryugina EI, Quigley JP. Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions. Biochim Biophys Acta 2010, 1803(1):103-120. 10.1016/j.bbamcr.2009.09.017, 2824055, 19800930.